Evidence map›Paper›PMID 41048965›Full record

ArticleFrontiers in medicine2025

Development and validation of a predictive model for invasive syndrome in patients with

Liyong Zhang, Jiaqi Chen, Yihao Qu, Xidong Cao, Jinhua Cui, Jian Li, Aijun Yu

Abstract read
In one paragraph

Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Journal of medical cases · 2026
    Article
  2. <p>Molecular medicine reports · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Liyong ZhangThe First Department of General Surgery, Affiliated Hospital of Chengde Medical University, Chengde, China.
Jiaqi ChenThe First Department of General Surgery, Affiliated Hospital of Chengde Medical University, Chengde, China.
Yihao QuThe First Department of General Surgery, Affiliated Hospital of Chengde Medical University, Chengde, China.
Xidong CaoThe First Department of General Surgery, Affiliated Hospital of Chengde Medical University, Chengde, China.
Jinhua CuiThe First Department of General Surgery, Affiliated Hospital of Chengde Medical University, Chengde, China.
Jian LiThe First Department of General Surgery, Affiliated Hospital of Chengde Medical University, Chengde, China.
Aijun YuThe First Department of General Surgery, Affiliated Hospital of Chengde Medical University, Chengde, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Pyogenic liver abscess (PLA) is a life-threatening liver bacterial infection causing suppurative lesions. In Asia, hypervirulent Methods: We retrospectively analyzed clinical data from 529 KPLA patients treated at Chengde Medical University Affiliated Hospital between August 1, 2014, and November 30, 2024. By using the 7:3 stratified random sampling method, the patients were assigned to two cohorts: derivation ( Results: Of the 529 enrolled patients, 33 patients (6.2%) developed IKPLAS (IKPLAS group), while the remaining 496 patients were included in the non-invasive group (NIKPLAS group). Both groups showed significant differences ( Conclusion: Viral hepatitis, T2DM, abscess diameter, presence of a gas-containing abscess, and SOFA score are the predictive factors of IKPLAS. The developed nomogram provides reliable risk stratification for patients with KPLA and can be applied clinically to predict IKPLAS cases.

Indexed as

invasive syndromeKlebsiella pneumoniaeliver abscessnomogrampredictive model

Identifiers

PMID41048965
PMCPMC12488649

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.